 |
2 Diseases |  |
2 Trials |
|
2 Trials |  |
7 News |  |
- |||||||||| AlloJoin (allogeneic human adipose-derived mesenchymal stem cell therapy) / Cellular Biomedicine
New P3 trial: Allogenic Adipose-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis (clinicaltrials.gov) - Aug 18, 2023
P3, N=488, Not yet recruiting, Sponsor: Cellular Biomedicine Group Ltd.
- || ReJoin (human adipose-derived mesenchymal progenitor cells) / Cellular Biomedicine
P2a data, Journal: Human adipose-derived mesenchymal progenitor cells plus microfracture and hyaluronic acid for cartilage repair: a Phase IIa trial. (Pubmed Central) - Jun 8, 2021
P2
These findings provide an impetus for future research on this treatment. ClinicalTrials.gov Identifier: NCT02855073.
- || ReJoin (human adipose-derived mesenchymal progenitor cells) / Cellular Biomedicine
Clinical, P1 data, Journal: Intra-articular injections of allogeneic human adipose-derived mesenchymal progenitor cells in patients with symptomatic bilateral knee osteoarthritis: a Phase I pilot study. (Pubmed Central) - Jun 8, 2021
MRI assessments showed slight improvements in the low-dose group. Safety and improvements in pain and function after intra-articular injections of allogeneic human adipose-derived mesenchymal progenitor cells into arthritic patients was demonstrated.
- |||| human adipose derived mesenchymal progenitor cell therapy / Cellular Biomedicine, ReJoin (human adipose-derived mesenchymal progenitor cells) / Cellular Biomedicine, AlloJoin (allogeneic human adipose-derived mesenchymal stem cell therapy) / Cellular Biomedicine
New P1/2 trial, Gram negative: A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection (clinicaltrials.gov) - Sep 9, 2020
P1/2, N=60, Recruiting, Sponsor: Ruijin Hospital
- | ReJoin (human adipose-derived mesenchymal progenitor cells) / Cellular Biomedicine
Enrollment closed, Trial completion date, Trial primary completion date: Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects (clinicaltrials.gov) - Dec 17, 2018
P2, N=28, Active, not recruiting, Sponsor: Cellular Biomedicine Group Ltd.
Safety and improvements in pain and function after intra-articular injections of allogeneic human adipose-derived mesenchymal progenitor cells into arthritic patients was demonstrated. Recruiting --> Active, not recruiting | Trial completion date: Dec 2016 --> Dec 2019 | Trial primary completion date: Dec 2016 --> Dec 2019
- | ReJoin (human adipose-derived mesenchymal progenitor cells) / Cellular Biomedicine
New P2 trial: Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects (clinicaltrials.gov) - Aug 4, 2016
P2, N=28, Recruiting, Sponsor: Cellular Biomedicine Group Ltd.